Topics: COVID-19
Events
AAHMS webinar – COVID-19: Where to from here?
Tweetchats with PRAXIS and ACTA
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
Academics & COVID-19: considerations and strategies for running trials during the pandemic
Clinical Trials for COVID-19 Treatment and Prevention
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
News
State and Territory Clinical Trials Contacts
FIND AND SHARE CLINICAL TRIAL SOLUTIONS AT BEYOND COVID-19: A SOLUTION-FOCUSSED FORUM
HealthMatch Clinical Trials Tracker – See clinical trials in action during the COVID-19 pandemic
Victorian Coordinating Office for Clinical Trial Research update
MHRA guidance on managing clinical trials during Coronavirus (COVID19)
NHMRC extensions due to COVID-19 impact on researchers
The UK’s EPPI-Centre has released a list of COVID-19 resources
ACTA statement on COVID-19
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
Medical Research Future Fund – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity open for applications – urgent call for research
Australian Commission on Safety and Quality in Health Care Health Service Accreditation (AHSSQA) during the COVID-19 pandemic
COVID-19 Expert Database
Tweetchats with PRAXIS and ACTA
Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry
NHMRC advice regarding grant administration matters
New South Wales Office for Health and Medical Research COVID-19 Guidance
Australian Commission on Safety and Quality in Health Care extends timeline for National Clinical Trials Governance Pilot due to COVID-19 pandemic
PRAXIS Managing Clinical Trials webinar recording now available
COVID-19 and clinical trial updates
National Medical Stockpile: Supply of experimental medicines to support clinical trials
ARCS Webinar Series: COVID-19: considerations and strategies for running trials during the pandemic
ClinTrial Refer COVID-19 app access
JAMA recommendations on maintaining clinical trial integrity during COVID-19 pandemic
FDA releases final update on managing clinical trials during COVID-19